614 related articles for article (PubMed ID: 18084158)
21. [Severe chronic anemia and endocrine disorders in children].
Hauschild M; Theintz G
Rev Med Suisse; 2007 Apr; 3(107):988-91. PubMed ID: 17526372
[TBL] [Abstract][Full Text] [Related]
22. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
23. The multifactorial origin of growth failure in thalassaemia.
Skordis N; Kyriakou A
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():271-7. PubMed ID: 21705977
[TBL] [Abstract][Full Text] [Related]
24. Low bone mineral density in adolescents with beta-thalassemia.
Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
[TBL] [Abstract][Full Text] [Related]
25. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
[TBL] [Abstract][Full Text] [Related]
26. Acquired central hypothyroidism in a male thalassaemic patient with severe iron overload.
De Sanctis V; Giovannini M
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():322-3. PubMed ID: 21705986
[TBL] [Abstract][Full Text] [Related]
27. Bone disease in thalassaemia major: recent advances in pathogenesis and clinical aspects.
Skordis N; Toumba M
Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():300-6. PubMed ID: 21705982
[TBL] [Abstract][Full Text] [Related]
28. Growth and puberty and its management in thalassaemia.
De Sanctis V
Horm Res; 2002; 58 Suppl 1():72-9. PubMed ID: 12373018
[TBL] [Abstract][Full Text] [Related]
29. Growth, puberty and endocrine function in beta-thalassaemia major.
Low LC
J Pediatr Endocrinol Metab; 1997; 10(2):175-84. PubMed ID: 9364350
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
31. Multicentre study on prevalence of endocrine complications in thalassaemia major. Italian Working Group on Endocrine Complications in Non-endocrine Diseases.
Clin Endocrinol (Oxf); 1995 Jun; 42(6):581-6. PubMed ID: 7634497
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
33. Outcome of thalassemia treated with conventional therapy.
Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
[No Abstract] [Full Text] [Related]
34. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
Kurtoglu AU; Kurtoglu E; Temizkan AK
Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
[TBL] [Abstract][Full Text] [Related]
36. Predicting pituitary iron and endocrine dysfunction.
Wood JC; Noetzl L; Hyderi A; Joukar M; Coates T; Mittelman S
Ann N Y Acad Sci; 2010 Aug; 1202():123-8. PubMed ID: 20712782
[TBL] [Abstract][Full Text] [Related]
37. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
38. MRI for the determination of pituitary iron overload in children and young adults with beta-thalassaemia major.
Christoforidis A; Haritandi A; Perifanis V; Tsatra I; Athanassiou-Metaxa M; Dimitriadis AS
Eur J Radiol; 2007 Apr; 62(1):138-42. PubMed ID: 17161570
[TBL] [Abstract][Full Text] [Related]
39. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
[TBL] [Abstract][Full Text] [Related]
40. Endocrinopathies in patients with transfusion-dependent beta-thalassemia.
Mehrvar A; Azarkeivan A; Faranoush M; Mehrvar N; Saberinedjad J; Ghorbani R; Vossough P
Pediatr Hematol Oncol; 2008; 25(3):187-94. PubMed ID: 18432501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
